Source: Russian Ministry of Defence | Read full Briefing | Briefing documents
We have repeatedly mentioned the role of U.S. Democratic Party representatives in funding bioweapons activities in Ukraine and the intermediary organisations that have been used for this purpose. I would like to refer to one of the key Pentagon contractors receiving money from Hunter Biden’s investment fund, Metabiota.
The available data suggests that the company is merely a front for internationally dubious purposes and is used by the U.S. political elite to carry out opaque financial activities in various parts of the world.
There is a specific example: Metabiota was involved in the response to the Ebola epidemic in West Africa. The activities of the company’s employees have raised questions from the World Health Organisation (WHO) in terms of their compliance with biosafety requirements.
This is the report of the international panel of experts from the Haemorrhagic Fever Consortium who were involved in the fight against Ebola virus disease in Sierra Leone in 2015.
According to the document, Metabiota staff had failed to comply with handling procedures and concealed the involvement of Pentagon staff who were using the company as a front. The main purpose of these activities was to isolate highly virulent variants of the virus from sick and dead people, as well as to export its strains to the USA.
In view of the apparent failure of Metabiota’s activities to meet the goals of controlling the spread of the disease, the World Health Organisation’s Ebola coordinator, Philippe Barbosa, recommended to recall the staff of the company saying he was extremely concerned about the potential risks of such collaboration to WHO’s reputation.
The U.S. military contractor’s heightened interest in the Ebola virus is not a coincidence: the disease is one of the most pathogenic to humans. During the outbreak that began in 2014, 28,000 people were contaminated, over 11,000 of them died, the mortality rate was around 40%.
The special military operation has led to receiving documents that reveals the plans of Metabiota and the Ukrainian Scientific-Technological Centre to study the Ebola virus in Ukraine.
This is the request for U.S. funding to diagnose highly dangerous pathogens in Ukraine, including Ebola virus. This kind of requests are part of U.S. strategy to redeploy high-risk work with dangerous pathogens to third countries.
The research was to be carried out at the Mechnikov Anti-Plague Institute in Odessa. As the disease is not endemic and has never been recorded in Ukraine indeed, there is a legitimate question about the need for such research and its true purpose.